Tag: American Society of Clinical Oncology

Immunotherapy continues to help improve cancer treatment in certain patients

Immunotherapy 2.0 named clinical advance of the year in cancer care. A lot of our updates are about new indications for immunotherapy to treat many types of cancer. This past year, new indications were approved for treatment in melanoma, bladder cancer, head and neck cancer, lung cancer and kidney cancer. While immunotherapy does not work… Read more »

Monitoring for cardiac dysfunction in cancer survivors

Certain cancer treatments, such as particular chemotherapy drugs (doxorubicin, trastuzumab) or radiation to the chest or breast tissue, can increase risk of patients developing cardiac dysfunction—either during treatment or later after treatment has completed. Patients at risk of developing heart complications from cancer treatment often need close communications between your oncologist, your primary care provider… Read more »